Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Linagliptin> ?p ?o. }
Showing items 1 to 83 of
83
with 100 items per page.
- Linagliptin abstract "Linagliptin (BI-1356, trade names Tradjenta and Trajenta) is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes.Linagliptin (once-daily) was approved by the U.S. Food and Drug Administration (FDA) on 2 May 2011 for treatment of type II diabetes. It is being marketed by Boehringer Ingelheim and Lilly.".
- Linagliptin atcPrefix "A10".
- Linagliptin atcSuffix "BH05".
- Linagliptin casNumber "668270-12-0".
- Linagliptin fdaUniiCode "3X29ZEJ4R2".
- Linagliptin iupacName "8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3- methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione".
- Linagliptin pubchem "10096344".
- Linagliptin thumbnail Linagliptin.png?width=300.
- Linagliptin wikiPageExternalLink www.tradjenta.com.
- Linagliptin wikiPageID "18475687".
- Linagliptin wikiPageRevisionID "604320788".
- Linagliptin atcPrefix "A10".
- Linagliptin atcSuffix "BH05".
- Linagliptin c "25".
- Linagliptin casNumber "668270".
- Linagliptin chembl "237500".
- Linagliptin chemspiderid "8271879".
- Linagliptin h "28".
- Linagliptin hasPhotoCollection Linagliptin.
- Linagliptin inchi "1".
- Linagliptin inchikey "LTXREWYXXSTFRX-QGZVFWFLBX".
- Linagliptin iupacName "8".
- Linagliptin kegg "D09566".
- Linagliptin legalUs "Rx-only".
- Linagliptin licenceEu "Trajenta".
- Linagliptin licenceUs "Linagliptin".
- Linagliptin medlineplus "a611036".
- Linagliptin molecularWeight "472.54".
- Linagliptin n "8".
- Linagliptin o "2".
- Linagliptin pregnancyUs "B".
- Linagliptin pubchem "10096344".
- Linagliptin routesOfAdministration "Oral".
- Linagliptin smiles "CC#CCN1C2=CNC".
- Linagliptin stdinchi "1".
- Linagliptin stdinchikey "LTXREWYXXSTFRX-QGZVFWFLSA-N".
- Linagliptin tradename "Tradjenta, Trajenta".
- Linagliptin unii "3".
- Linagliptin verifiedfields "changed".
- Linagliptin verifiedrevid "452028402".
- Linagliptin watchedfields "changed".
- Linagliptin subject Category:Alkynes.
- Linagliptin subject Category:Dipeptidyl_peptidase-4_inhibitors.
- Linagliptin subject Category:Piperidines.
- Linagliptin subject Category:Quinazolines.
- Linagliptin subject Category:Xanthines.
- Linagliptin type Abstraction100002137.
- Linagliptin type Acetylene114600742.
- Linagliptin type AliphaticCompound114601294.
- Linagliptin type Alkynes.
- Linagliptin type Base114618253.
- Linagliptin type Chemical114806838.
- Linagliptin type Compound114818238.
- Linagliptin type Material114580897.
- Linagliptin type Matter100020827.
- Linagliptin type OrganicCompound114727670.
- Linagliptin type Part113809207.
- Linagliptin type PhysicalEntity100001930.
- Linagliptin type Purine114706749.
- Linagliptin type Purines.
- Linagliptin type Relation100031921.
- Linagliptin type Substance100019613.
- Linagliptin type Drug.
- Linagliptin type DrugProduct.
- Linagliptin type FunctionalSubstance.
- Linagliptin comment "Linagliptin (BI-1356, trade names Tradjenta and Trajenta) is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes.Linagliptin (once-daily) was approved by the U.S. Food and Drug Administration (FDA) on 2 May 2011 for treatment of type II diabetes. It is being marketed by Boehringer Ingelheim and Lilly.".
- Linagliptin label "Linagliptin".
- Linagliptin label "Linagliptin".
- Linagliptin label "Linagliptine".
- Linagliptin label "Linagliptine".
- Linagliptin label "利拉利汀".
- Linagliptin sameAs Linagliptin.
- Linagliptin sameAs Linagliptine.
- Linagliptin sameAs リナグリプチン.
- Linagliptin sameAs Linagliptine.
- Linagliptin sameAs m.04dy_8j.
- Linagliptin sameAs Q909745.
- Linagliptin sameAs Q909745.
- Linagliptin sameAs Linagliptin.
- Linagliptin wasDerivedFrom Linagliptin?oldid=604320788.
- Linagliptin depiction Linagliptin.png.
- Linagliptin homepage www.tradjenta.com.
- Linagliptin isPrimaryTopicOf Linagliptin.